Stocks
FibroBiologics, Inc.FBLG
NASDAQHealthcareBiotechnology$0.98
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing fibroblast-based cell therapies for chronic diseases, including degenerative disc disease and multiple sclerosis. Its pipeline centers on allogeneic fibroblast platforms, and investors track it for early-stage regenerative medicine upside and upcoming clinical milestones.
52W Range: $0.62-$9.60
Congressional Interest in FibroBiologics, Inc. (FBLG)
No congressional trades have been disclosed for FibroBiologics, Inc. (FBLG) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading FBLG?
No congressional trades found for this stock.